...
首页> 外文期刊>Japanese journal of clinical oncology. >Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients.
【24h】

Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients.

机译:巢式rt-PCR检测乳腺癌患者角蛋白19的骨髓微转移的临床意义。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: Breast cancers in the early phase frequently undergo distant metastasis and survival of patients is greatly dependent on distant metastasis. The occurrence of micrometastasis has been suggested to relate with prognostic features of breast cancer, such as lymph node metastasis and the presence of vascular invasion. The aim of this study was to examine the presence of keratin-19 mRNA of epithelial tumors in bone marrow aspirates obtained from breast cancer patients and its possible correlation with tumor staging and disease-free survival. METHODS: Bone marrow samples were obtained from 59 breast cancer patients at the time of surgery. We separated the mononuclear fraction from the samples and carried out nested reverse transcriptase polymerase chain reaction (RT-PCR) for the detection of keratin-19 mRNA with two different pairs of primers. After operation, the patients were followed up at 3-month intervals. We studied the possible correlation of the detection of keratin-19 mRNA with tumor size, nodal involvement, stage and recurrence rate. RESULTS: Bone marrow micrometastasis was detected by nested RT-PCR for keratin-19 mRNA in one of four patients with ductal carcinoma in situ (DCIS), 13 of 30 patients with T1, 11 of 20 patients with T2 and all four patients with T3 lesion. Recurrence was observed in seven cases and all of them were positive for micrometastasis in bone marrow. CONCLUSION: The method of nested RT-PCR to detect the presence of keratin-19 mRNA in bone marrow from patients with breast cancer is sensitive and reliable. Moreover, early recurrence was observed in the patients with the tumor mRNA detected in bone marrow. Additional studies with larger numbers of patients and longer follow-up are desirable.
机译:目的:早期乳腺癌经常发生远处转移,患者的生存在很大程度上取决于远处转移。有人认为微转移的发生与乳腺癌的预后特征有关,例如淋巴结转移和血管浸润的存在。这项研究的目的是检查从乳腺癌患者获得的骨髓穿刺物中上皮肿瘤角蛋白19 mRNA的存在及其与肿瘤分期和无病生存的可能关系。方法:在手术时从59例乳腺癌患者中获得了骨髓样本。我们从样品中分离出单核部分,并进行了嵌套的逆转录聚合酶链反应(RT-PCR),用两对不同的引物检测角蛋白19 mRNA。手术后,每三个月对患者进行一次随访。我们研究了角蛋白19 mRNA的检测与肿瘤大小,淋巴结受累,分期和复发率之间的可能相关性。结果:通过巢式RT-PCR检测了4例导管原位癌(DCIS)患者中的1例,30例T1患者中的13例,20例T2患者中的11例以及所有4例T3患者的骨髓微转移病变。复发7例,均为骨髓微转移阳性。结论:巢式RT-PCR检测乳腺癌患者骨髓中角蛋白19 mRNA的存在是灵敏可靠的。此外,在骨髓中检测到肿瘤mRNA的患者中观察到了早期复发。希望有更多的患者和更长的随访时间进行附加研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号